BMX-001 acts as a selective chemoradioprotector in rectal cancer
Redox Biochemistry and Chemistry · 2026-06 · 16 · 100074
DOI: 10.1016/j.rbc.2026.100074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biochemistry and Chemistry, 2026-06. Verfasst von Molly S Myers und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
- Nebraska Center for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE, 68588, USA.
- Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
- Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
- Department of Surgery, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
- Department of Medicine, Duke University Medical Center, Durham, NC, 27710, USA.
ORCID-Profile: Molly S Myers, Chia Sin Liew, Melinda Wojtkiewicz, Pooja Roy, R Katherine Hyde, Ivan Spasojevic, Kyle J Hewitt, Jean-Jack M Riethoven, Rebecca E Oberley-Deegan
Förderung
- NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- National Institutes of Health National Cancer Institute
- National Institutes of Health
- National Institute of General Medical Sciences
- University of Nebraska-Lincoln Nebraska Center for the Prevention of Obesity Diseases
- National Institutes of Health Office of the Director
Zitieren
APA
Myers, M. S., Kosmacek, E. A., Liew, C. S., Chatterjee, A., Wojtkiewicz, M., Roy, P., Hyde, R. K., Dhawan, P., Spasojevic, I., Wang, S., Hewitt, K. J., Furdui, C. M., Gundry, R. L., Riethoven, J. M., Lin, C., & Oberley-Deegan, R. E. (2026). BMX-001 acts as a selective chemoradioprotector in rectal cancer. Redox Biochemistry and Chemistry, 16, 100074. https://doi.org/10.1016/j.rbc.2026.100074
Vancouver
Myers MS, Kosmacek EA, Liew CS, Chatterjee A, Wojtkiewicz M, Roy P, et al. BMX-001 acts as a selective chemoradioprotector in rectal cancer. Redox Biochemistry and Chemistry. 2026;16:100074. doi:10.1016/j.rbc.2026.100074
BibTeX
@article{Myers2026,
author = {Myers, Molly S and Kosmacek, Elizabeth A and Liew, Chia Sin and Chatterjee, Arpita and Wojtkiewicz, Melinda and Roy, Pooja and Hyde, R Katherine and Dhawan, Punita and Spasojevic, Ivan and Wang, Shuo and Hewitt, Kyle J and Furdui, Cristina M and Gundry, Rebekah L and Riethoven, Jean-Jack M and Lin, Chi and Oberley-Deegan, Rebecca E},
title = {BMX-001 acts as a selective chemoradioprotector in rectal cancer},
journal = {Redox Biochemistry and Chemistry},
year = {2026},
volume = {16},
pages = {100074},
doi = {10.1016/j.rbc.2026.100074}
}
EUVIMED